Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Bulitta

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|March 20, 2013
Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector FunctionsMaxi Scheiter, Björn Bulitta, Marco van Ham, et al.
Kidney International Reports|November 13, 2024
Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney TransplantationLena Brunkhorst, Michael Terhardt, Björn Bulitta, et al.
Kidney International Reports|July 18, 2025
Corrigendum to "Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney Transplantation" [<i>Kidney International Reports</i> Volume 9, Issue 11, November 2024, Pages 3236-3249]Lena Brunkhorst, Michael Terhardt, Björn Bulitta, et al.
Hepatology Communications|January 21, 2026
Measuring MMP-7 levels in dried blood spots appears not feasible for newborn screening of biliary atresiaMarie Uecker, Björn Bulitta, Nils Janzen, et al.
European Journal of Immunology|May 12, 2018
Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotypeBjörn Bulitta, Werner Zuschratter, Isabel Bernal, et al.
Molecular & Cellular Proteomics : MCP|January 15, 2013
Proteome analysis of distinct developmental stages of human natural killer (NK) cellsMaxi Scheiter, Ulrike Lau, Marco van Ham, et al.
Frontiers in Microbiology|November 10, 2018
<i>Clostridioides difficile</i> Activates Human Mucosal-Associated Invariant T CellsIsabel Bernal, Julia Danielle Hofmann, Björn Bulitta, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 20, 2013
Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector FunctionsMaxi Scheiter, Björn Bulitta, Marco van Ham, et al.
Kidney International Reports|November 13, 2024
Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney TransplantationLena Brunkhorst, Michael Terhardt, Björn Bulitta, et al.
Kidney International Reports|July 18, 2025
Corrigendum to "Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney Transplantation" [<i>Kidney International Reports</i> Volume 9, Issue 11, November 2024, Pages 3236-3249]Lena Brunkhorst, Michael Terhardt, Björn Bulitta, et al.
Hepatology Communications|January 21, 2026
Measuring MMP-7 levels in dried blood spots appears not feasible for newborn screening of biliary atresiaMarie Uecker, Björn Bulitta, Nils Janzen, et al.
European Journal of Immunology|May 12, 2018
Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotypeBjörn Bulitta, Werner Zuschratter, Isabel Bernal, et al.
Molecular & Cellular Proteomics : MCP|January 15, 2013
Proteome analysis of distinct developmental stages of human natural killer (NK) cellsMaxi Scheiter, Ulrike Lau, Marco van Ham, et al.
Frontiers in Microbiology|November 10, 2018
<i>Clostridioides difficile</i> Activates Human Mucosal-Associated Invariant T CellsIsabel Bernal, Julia Danielle Hofmann, Björn Bulitta, et al.
Pageof 1